Sandoz, the generic pharmaceuticals division of Novartis, is a worldwide leader in generics. With a history of more than 120 years, Sandoz is a trusted leader with a reputation for exceptional quality.
Our strategic and customer-focused approach to developing, producing and marketing high-quality affordable medicines following the loss of patent protection, has successfully made us one of the two largest and most respected generics companies worldwide.
Our medicines are already available to 90 percent of people across the world and we are committed to further increasing global access to affordable healthcare.
This site uses our own and third pary owned cookies, in order to give you a personalized service. If you continue to navigate on our site, we consider you accept their use. Either way, you can change the settings on your browser. For more information, please refer to our privacy policy.